The hedgehog (Hh) signaling pathway plays fundamental roles during embryonic development and tumo... more The hedgehog (Hh) signaling pathway plays fundamental roles during embryonic development and tumorigenesis. Previously, we have shown that ablation of the tumor suppressor and negative regulator, Suppressor of fused (Sufu), within this pathway causes embryonic lethality around E9.5 in the mouse. Here, we examine how lack of Sufu influences early cell fate determination processes. We established embryonic stem cell (ESC) lines from pre-implantation Sufu-/- and wild-type mouse embryos and show that these ESCs express the typical pluripotency markers, alkaline phosphatase, SSEA-1, Oct4, Sox2, and Nanog. We demonstrate that these ESCs express all core Hh pathway components, and that Gli1 mRNA levels are increased in Sufu-/- ESCs. Upon spontaneous differentiation of Sufu-/- ESCs, into embryoid bodies (EBs) in vitro, the Hh pathway is strongly upregulated as indicated by an increase in both Gli1 and Ptch1 gene expression. Interestingly, developing Sufu-/- EBs were smaller than their wild-type counterparts and showed decreased expression of the ectodermal markers Fgf5 and Sox1. In vivo teratoma formation revealed that Sufu-/- ESCs have a limited capacity for differentiation as the resulting tumors lacked the mesodermal derivatives cartilage and bone. However, Sufu-/- ESCs were able to develop into chondrocytes and osteocytes in vitro, which suggests a differential response of ESCs compared to in vivo conditions. Our findings suggest a regulatory function of the Hh signaling pathway in early mesodermal cell fate determination and emphasize the role of Sufu as a key molecule in this process.
The hedgehog (Hh) signaling pathway plays fundamental roles during embryonic development and tumo... more The hedgehog (Hh) signaling pathway plays fundamental roles during embryonic development and tumorigenesis. Previously, we have shown that ablation of the tumor suppressor and negative regulator, Suppressor of fused (Sufu), within this pathway causes embryonic lethality around E9.5 in the mouse. Here, we examine how lack of Sufu influences early cell fate determination processes. We established embryonic stem cell (ESC) lines from pre-implantation Sufu-/- and wild-type mouse embryos and show that these ESCs express the typical pluripotency markers, alkaline phosphatase, SSEA-1, Oct4, Sox2, and Nanog. We demonstrate that these ESCs express all core Hh pathway components, and that Gli1 mRNA levels are increased in Sufu-/- ESCs. Upon spontaneous differentiation of Sufu-/- ESCs, into embryoid bodies (EBs) in vitro, the Hh pathway is strongly upregulated as indicated by an increase in both Gli1 and Ptch1 gene expression. Interestingly, developing Sufu-/- EBs were smaller than their wild-type counterparts and showed decreased expression of the ectodermal markers Fgf5 and Sox1. In vivo teratoma formation revealed that Sufu-/- ESCs have a limited capacity for differentiation as the resulting tumors lacked the mesodermal derivatives cartilage and bone. However, Sufu-/- ESCs were able to develop into chondrocytes and osteocytes in vitro, which suggests a differential response of ESCs compared to in vivo conditions. Our findings suggest a regulatory function of the Hh signaling pathway in early mesodermal cell fate determination and emphasize the role of Sufu as a key molecule in this process.
Uploads
Papers by Maria Kasper